Abstract
Background: Thiazolidinone-4-ones belong to important heterocyclic compounds because of their broad spectrum of biological activities. Several methods for the synthesis of 4- thiazolidinones are reported in the literature. The main synthetic route to synthesize 1,3-thiazolidin- 4-ones is the three-component reaction between amine, a carbonyl compound and a mercapto-acid.
Objective: Dapsone-Cu supported on silica coated Fe3O4 (Fe3O4@SiO2-pr@dapsone-Cu) as a new heterogeneous nanoparticle catalyst was synthesized and the structure and morphology of this catalyst were characterized by Fourier transform infrared spectroscopy (FT-IR), Xray diffraction (XRD), transmission electron microscopy (TEM), field emission scanning electron microscopy (FESEM), energy-dispersive X-ray spectroscopy (EDX), zeta potential, vibrating sample magnetometry (VSM) and thermal gravimetric analysis (TGA). The new synthesized catalyst was applied as an effective nanocatalyst for the synthesis of new derivatives of azo-linked thiazolidinones through one-pot multi-component reaction of various aromatic aldehydes, thioglycolic acid and 4- aminoazobenzene under solvent-free condition.
Methods:A mixture of aldehyde, thioglycolic acid, 4-aminoazobenzene (1 mmol) and 0.05 g Fe3O4@SiO2@dapsone-Cu MNPs was stirred at room temperature under solvent-free condition.
Results: A facile, green, new and efficient method for the synthesis of thiazolidine-4-ones through three component reaction of various aldehydes, thioglycolic acid and 4-aminoazobenzene in the presence of Fe3O4@SiO2-propyl@dapsone-Cu complex under solvent-free reaction was reported.
Conclusion: This new procedure has notable advantages such as excellent yields, short reaction time, operational simplicity, easy work-up, eco-friendly and using a non-toxic catalyst. Also, the catalyst is easily recoverable in the presence of an enormous magnet and reused for six consecutive reaction cycles without significant loss of activity.
Keywords: Fe3O4@SiO2-pr@dapsone-Cu, solvent-free, azo dispersive dyes, thiazolidine-4-ones, solvatochromism, heterocyclic compounds
Graphical Abstract
[http://dx.doi.org/10.1080/10426500802561096]
[http://dx.doi.org/10.1158/1535-7163.MCT-08-1037] [PMID: 19509254]
[http://dx.doi.org/10.1016/j.jfluchem.2012.10.012]
[http://dx.doi.org/10.1016/j.bmc.2012.04.007] [PMID: 22546208]
[http://dx.doi.org/10.1016/j.bmc.2012.07.016] [PMID: 22867707]
[http://dx.doi.org/10.1016/j.bmc.2010.04.045] [PMID: 20471839]
[http://dx.doi.org/10.1016/j.bmc.2009.06.065] [PMID: 19635672]
[http://dx.doi.org/10.1016/j.bmcl.2007.05.039] [PMID: 17537628]
[http://dx.doi.org/10.1039/C9RA08649H]
[http://dx.doi.org/10.1016/j.jfluchem.2005.10.016]
[http://dx.doi.org/10.1016/j.bmcl.2007.05.059] [PMID: 17561392]
[http://dx.doi.org/10.1016/j.ejmech.2014.08.046]
[http://dx.doi.org/10.1016/j.bmc.2006.12.003] [PMID: 17178227]
[http://dx.doi.org/10.3390/scipharm88010016]
[http://dx.doi.org/10.1016/j.bioorg.2018.06.036] [PMID: 29986191]
[http://dx.doi.org/10.3998/ark.5550190.0008.e08]
[http://dx.doi.org/10.3390/molecules23030685] [PMID: 29562646]
[http://dx.doi.org/10.3390/molecules24112060]
[http://dx.doi.org/10.1016/j.tetlet.2015.10.037]
[http://dx.doi.org/10.1007/s00044-013-0736-8]
[http://dx.doi.org/10.1021/jm9900927] [PMID: 10447958]
[http://dx.doi.org/10.1007/s00044-011-9679-0]
[http://dx.doi.org/10.3987/COM-05-10494]
[http://dx.doi.org/10.1023/B:COHC.0000027896.38910.d1]
[http://dx.doi.org/10.1016/j.dyepig.2016.03.038]
[http://dx.doi.org/10.2174/1570179411666140806005614]
[http://dx.doi.org/10.2174/157017812801264719]
[http://dx.doi.org/10.1002/jhet.2686]
[http://dx.doi.org/10.1002/jhet.2686]
[http://dx.doi.org/10.1016/j.cclet.2009.11.032]
[http://dx.doi.org/10.1039/C8RA02572J]
[http://dx.doi.org/10.1039/C8RA02572J]
[http://dx.doi.org/10.1016/j.jorganchem.2019.05.004]
[http://dx.doi.org/10.1134/S107036321409031X]